Senate Democrats boycott committee vote on Mnuchin, Price

File photo of Steven Mnuchin testifying on his nomination to be Treasury secretary in WashingtonWASHINGTON (Reuters) – U.S. Senate Democrats on Tuesday boycotted a planned committee vote on two of President Donald Trump's nominees, Steve Mnuchin to be Treasury Secretary and Tom Price to head the Health and Human Services department, making it impossible for the vote to go forward. Democrats said they were delaying the vote because they wanted more information on Price's stock trades in an Australian medical company and reports that Mnuchin's former bank, OneWest, used automated "robosignings" of foreclosures, which apparently contradicted statements he made to senators. …

Go to Source

As Teva wins U.S. approval for GSK Advair copy, main fight yet to come

Signage for GlaxoSmithKline is seen on it's offices in London, BritainBy Ben Hirschler LONDON (Reuters) – Israel&;s Teva Pharmaceutical Industries has won U.S. approval to market a copy of GlaxoSmithKline&039;s best-selling Advair inhaler, although the real battle is still to come. Teva&039;s version of GSK&039;s blockbuster medicine, called AirDuo RespiClick, is not directly substitutable for Advair and is only approved for asthma, while Advair is also widely used for chronic obstructive pulmonary disease (COPD). Teva said on Monday it would launch AirDuo later this year.

Go to Source

1 2 3 11